ClinicalTrials.govpublic full text
Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
breast cancer, triple-negative breast cancer, pathological complete response, neoadjuvant therapy, posaconazole, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 873409
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.